Krka expects bribery investigation results by end of month
Novo Mesto, 17 January - The Slovenian pharma Krka said on Friday that its internal investigation into alleged bribery activities in the company's Romanian subsidiary was expected to be completed by the end of January. If any irregularities affecting Krka's business performance are indeed uncovered, the drug maker would publicly report on them.
The rest of this news item is available to subscribers.
The news item consists of 1.189 characters (without spaces) or 213 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.